Literature DB >> 8328363

Effects of angiotensin-converting enzyme inhibition with perindopril on hemodynamics, arterial structure, and wall rheology in the hindquarters of atherosclerotic mini-pigs.

P H Rolland1, P Charpiot, A Friggi, P Piquet, A Barlatier, E Scalbert, H Bodard, P Tranier, C Mercier, R Luccioni.   

Abstract

The effects of ACE inhibition with perindopril on the atherosclerosis-induced impairment of arterial flow were investigated via histopathologic studies, hemodynamics, and vascular rheology of hindlimb arteries in 7 adult Pitman-Moore mini-pigs (7 months of age) fed for 4 months with an atherogenic diet and perindopril (at the daily oral dose of 4 mg, which induced a continuous 70% inhibition of serum ACE activity), versus 7 atherogenic and 7 control animals. Major fibroproliferative fatty lesions with medial intimalization were observed in the abdominal aorta. Atherosclerosis impaired the function of both capacitance and resistance hindlimb arteries. In atherogenic mini-pigs, blood pressure (BP) increased significantly due to increased hindlimb peripheral resistance (HPR) and aortic input impedance, although aortic blood flow was not affected. Altered aortic wall rheology revealed that the stiffness of the aorta was markedly increased due to increased wall tension and reduced viscoelasticity, the viscous component being reduced in the arterial wall. Perindopril significantly opposed these alterations by reducing BP, HPR and input impedance and by returning parietal stiffness to control values by increasing aortic compliance. Angiotensin converting enzyme (ACE) inhibition significantly prevented the development of atherosclerosis in the abdominal aorta by decreasing the cross-sectional area of lesions and the presence of lipid-laden cells, as well as by preventing alteration and fragmentation of elastic laminae. In conclusion, ACE inhibition with perindopril showed a significant preventive action on atherosclerosis-induced deleterious effects on vascular wall function and structure in mini-pig arteries.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8328363     DOI: 10.1016/0002-9149(93)90948-c

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Bradykinin-mediated cardiovascular protective actions of ACE inhibitors. A new dimension in anti-ischaemic therapy?

Authors:  W J Remme
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 2.  Emerging concepts: angiotensin-converting enzyme inhibition in coronary artery disease.

Authors:  G B Mancini
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 3.  Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease.

Authors:  R Ferrari; C Ceconi; S Curello; P Pepi; A Mazzoletti; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 4.  Effect of Angiotensin-converting enzyme inhibitors and Angiotensin receptor antagonists in atherosclerosis prevention.

Authors:  Maria M Patarroyo Aponte; Gary S Francis
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

Review 5.  Peripheral artery disease: potential role of ACE-inhibitor therapy.

Authors:  Giuseppe Coppola; Giuseppe Romano; Egle Corrado; Rosa Maria Grisanti; Salvatore Novo
Journal:  Vasc Health Risk Manag       Date:  2008

Review 6.  Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis.

Authors:  Eva Lonn
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.